Figure 2. Upregulation of RPL6 and Cyclin E expression shorten patients' survival time after followed up.
A. Patients with both RPL6 and Cyclin E positive, RPL6 positive and Cyclin E negative, RPL6 negative and Cyclin E positive, both RPL6 and Cyclin E negative. B. Patients with RPL6 positive and negative. C. Patients with Cyclin E positive and negative. p<0.01 vs both RPL6 and Cyclin E positive and the corresponding control; * p<0.01 vs RPL6 positive and RPL6 negative.